Skip to main content
OpenTrials
Completed

NCT Number: NCT07090980

Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients

Seventy epilepsy patients who presented to Gaziosmanpaşa Training and Research Hospital as outpatients (diagnosed at least 3 months prior, taking at least one medication, and having access to the internet) were randomly assigned to two groups. 35 patients were assigned to the experimental group, and 35 patients to the control group. All patients were asked to complete a sociodemographic form, self-management form, medication adherence form, and stigma form as pre-tests. The experimental group was exposed to an epilepsy education podcast recorded by the researcher via Spotify. The control group received routine outpatient education provided by the doctor. The same tests were repeated at 1 and 3 months, and the effectiveness of the education was evaluated. Differences between the two groups and changes over time were monitored.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gaziosmanpaşa Eğitim ve Araştırma Hastanesi

Istanbul, gaziosmanpaşa, 34100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteer to participate in the study
  • 18 years of age
  • Diagnosed with epilepsy at least 3 months ago
  • Taking at least one antiepileptic drug

Exclusion criteria

  • Being diagnosed with mental retardation
  • Having language and communication barriers
  • Not having sufficient equipment

Treatment and study plan

epilepsy education via podcast

Other

Epilepsy education via podcast has never been provided in any clinical study in Turkey before. By providing education via podcast, we have made health education more accessible and repeatable.

Primary outcomes

  1. first month results

    Time frame: 1 month result

    Members of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the "Patient Information Form," the "Medication Beliefs Questionnaire," the "Feeled Stigma Scale," and the "Self-Management Scale." The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.

Secondary outcomes

  1. third month result

    Time frame: three months

    Members of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the "Patient Information Form," the "Medication Beliefs Questionnaire," the "Feeled Stigma Scale," and the "Self-Management Scale." The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.

Sponsors and collaborators

Lead sponsor

Istanbul Sabahattin Zaim University

Other

Registry information

Official study title

Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients.

Acronym: epilepsy

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 29, 2025
Registry last updated
Jul 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.